Skip to main content

1 Result(s)

within Yu-xian Bai Remove this filter Internal Medicine Remove this filter

and

  1. No Access

    Article

    Bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as the second-line therapy for patients with metastatic colorectal cancer, a multicenter study

    Poor prognosis is associated with patients with metastatic colorectal cancer. To seek effective methods, we examine the efficacy and safety of bevacizumab plus FOLFIRI as a second-line chemotherapy in Chinese...

    Ting Deng, Le Zhang, **ao-jian Liu, Jian-ming Xu, Yu-xian Bai, Yan Wang… in Medical Oncology (2013)